Home
Tag
Ramesh Babu Potluri
1 article
Results
SMS Pharma Q1 Net Profit Rises 16% YoY
SMS Pharmaceuticals reported Q1 FY27 standalone net profit of ₹21.13 Cr, a 16% YoY increase from ₹18.21 Cr in Q1 FY26. The Board approved a ₹50 Cr loan to subsidiary SMS Peptides and re-appointed Rame